U.S. markets close in 5 hours 51 minutes
  • S&P 500

    4,118.03
    -22.03 (-0.53%)
     
  • Dow 30

    32,778.02
    -54.52 (-0.17%)
     
  • Nasdaq

    12,462.39
    -182.07 (-1.44%)
     
  • Russell 2000

    1,925.12
    -16.08 (-0.83%)
     
  • Crude Oil

    91.88
    +1.12 (+1.23%)
     
  • Gold

    1,814.00
    +8.80 (+0.49%)
     
  • Silver

    20.52
    -0.09 (-0.43%)
     
  • EUR/USD

    1.0242
    +0.0047 (+0.46%)
     
  • 10-Yr Bond

    2.8030
    +0.0380 (+1.37%)
     
  • GBP/USD

    1.2112
    +0.0030 (+0.25%)
     
  • USD/JPY

    134.9790
    +0.0060 (+0.00%)
     
  • BTC-USD

    23,066.96
    -1,075.79 (-4.46%)
     
  • CMC Crypto 200

    535.24
    -22.11 (-3.97%)
     
  • FTSE 100

    7,493.39
    +11.02 (+0.15%)
     
  • Nikkei 225

    27,999.96
    -249.28 (-0.88%)
     

Why Is Pfizer Teaming Up With Acuitas Therapeutics?

·3 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Pfizer (NYSE: PFE) is putting some of its growing cash stockpile to use. The big drugmaker recently announced a collaboration with Acuitas Therapeutics. In this Motley Fool Live video, recorded on Jan. 12, Fool contributors Keith Speights and Brian Orelli discuss why Pfizer is teaming up with Acuitas.